Jenna Rychert, PhD

Adjunct Associate Professor, University of Utah School of Medicine

Education

• Doctorate Degree—Microbiology, Immunology, and Parasitology; Louisiana State Health Sciences Center
• Postdoctoral Training—HIV Immunology, Harvard Medical School/Massachusetts General Hospital
• Fellowship—Clinical Microbiology, Harvard Medical School/Massachusetts General Hospital

Certification/Affiliations

• American Board of Medical Microbiology (ABMM)
• Laboratory Logical Observation Identifier Names and Codes (LOINC) Committee
• American Society of Microbiology (ASM)
• American Medical Informatics Association (AMIA)

Research Interests

• Laboratory informatics
• Interoperability
• Regulatory affairs
• Global health

Awards and Community Service

• Global Health Travel Award, Center for Global Health, Massachusetts General Hospital, 2012 and 2014
• Medical Mission Member, Wide Horizons for Children, Ethiopia, 2009-2013, 2015, and 2019

Recent Publications

• Genzen JR, et al. Integrity of SARS-CoV-2 laboratory-developed tests. JAMA. 2022;328(5):478.
• Slev P, et al. 11.29 Serologic tests for diagnosis of Histoplasma capsulatum, 11.29.3 Histoplasma capsulatum antibody detection by immunodiffusion (ID). In: Leber AL, Burnham CAB, eds. Clinical Microbiology Procedures Handbook. 4th ed. ASM Press; 2022: 11.29.3.1–3.4.
• Rychert J, et al. Evaluation of 3 SARS-CoV-2 IgG antibody assays and correlation with neutralizing antibodies. J Appl Lab Med. 2021;6(3):614–24.
• Rychert J, et al. Modification of in vitro diagnostic devices: leveling the playing field. Clin Chem. 2020;66(6):760–2.
• Body BA, et al. Evaluation of the Vitek MS v3.0 matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Mycobacterium and Nocardia species. J Clin Microbiol. 2018;56(6):e00237-18.